Partner Headlines - GSK

  1. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  2. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  3. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  4. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  5. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  6. Action Heats Up in Ebola-Related Equities

    FoxBusiness
  7. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus
  8. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  9. Royal Bank of Scotland

    IBD
  10. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD
  11. International Securities For A Diversified Income Portfolio

    GuruFocus
  12. Could European Funds Offer An Opportunity Now?

    Benzinga
  13. Widely Held Guru Stocks Trading In Europe

    GuruFocus
  14. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  15. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus
  16. China Fines Glaxo For Bribes

    IBD
  17. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  18. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  19. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  20. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  21. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  22. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  23. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  24. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  25. Intermune up on buyout buzz

    IBD
  26. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  27. Drugmaker AstraZeneca Returns To Growth

    IBD
  28. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  29. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  30. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  31. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  32. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  33. A Look at the Week's Top Dividend Growers

    GuruFocus
  34. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  35. GlaxoSmithKline

    IBD
  36. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  37. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  38. Morning Market Movers

    Benzinga
  39. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  40. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  41. British Stocks: Sweet Spot For European Value

    YCharts
  42. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  43. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  44. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  45. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  46. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  47. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  48. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  49. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  50. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  51. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  52. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  53. Can Pfizer Make Up Its Loss?

    GuruFocus
  54. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  55. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  56. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  57. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  58. Glaxo hurt by Advair scandal

    IBD
  59. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  60. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  61. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  62. China Rule Change Further Opens Yuan To World Markets

    IBD
  63. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  64. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine ...

    Benzinga
  65. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  66. Benzinga Weekly Preview: Earnings Season Continues As Biotech ...

    Benzinga
  67. Big Pharmas Swap Specialties

    IBD
  68. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  69. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  70. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  71. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  72. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  73. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  74. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  75. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  76. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  77. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  78. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  79. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  80. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  81. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  82. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes ...

    GuruFocus
  83. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  84. Pharmaceutical Stocks For Income, Value, And Growth Investors

    Benzinga
  85. New Glaxo bribery inquiries

    IBD
  86. Race for Vaccines, Treatments as West Africa Ebola Death Toll ...

    Benzinga
  87. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  88. GlaxoSmithKline

    IBD
  89. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  90. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  91. Glaxosmithkline Confirms Warning Letter Received from FDA o March ...

    Benzinga
  92. GSK buys up Indonesia unit

    IBD
  93. GSK Recalls Alli in U.S. After Package Tampering

    FoxBusiness
  94. GSK, FDA Probe Tampering of Weight-Loss Drug Alli

    FoxBusiness
  95. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  96. Market Wrap For March 20: Investors Showing No Post-Fed Decision ...

    Benzinga
  97. Glaxo Cancer Vaccine Fails, Testing Continues

    FoxBusiness
  98. Morning Market Losers

    Benzinga
  99. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga
  100. Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does ...

    Benzinga
Trading Center